Wednesday, 18 May, 2022
TopicNPPA

Topic: NPPA

Modi govt caps trade margin of oxygen concentrators at 70%

Manufacturers and importers have been asked to report revised MRP within three days. Currently, the margin on oxygen concentrators at the distributor level ranges up to 198%.

‘Prescription audit’ soon to assess use of drug cocktails in India and check over-medication

Drug price regulator's decision comes amid increase in approvals to fixed dose combination medicines or drug cocktails that it says could pose health hazard.

Cipla, Sun Pharma, Lupin on drug price watchdog’s new list of firms ‘overcharging consumers’

NPPA has issued a list of  ‘overcharging cases’ under litigation, which includes matters dating back to 1997 & those where firms have moved court against the allegations.

Drug price watchdog plans to raise ‘public health’ concerns over cocktail drugs before govt

An increasing number of fixed dose combination drugs is not desirable in the overall public interest and welfare, says the National Pharmaceutical Pricing Authority.

Drug price regulator NPPA worried about drug cocktails, flags ‘over-medication, profiteering’

The NPPA observations came this week as it took up applications to fix the prices of 34 new drugs, most of which were fixed-dose combination medicines or drug cocktails.

Drug pricing regulator NPPA caps price of liquid medical oxygen, cylinders for 6 months

Covid-19 has increased demand for medical oxygen by almost four times from 750 MT per day to around 2,800 MT per day, the Ministry of Chemicals and Fertilizers said.

Watchdog on pharma ethics violations says it has no such power in RTI reply, takes U-turn later

NPPA has been seeking reports from industry bodies on complaints regarding violations of the self-regulatory mechanism meant to discourage pharma malpractices. But it said in reply to an RTI query that this isn't part of its mandate. 

Modi govt to form standing committee to prevent drugmakers from evading price control

Representatives from NPPA, CDSCO and DGHS to be part of the standing committee, which will have mandate to approve the drug discontinuation applications.

Prices of some medicines could go up as cost of Chinese bulk drugs import surges

Drug makers have reached out to Modi govt with a proposal to bring a law under which price hikes could be made possible due to unforeseen factors.

Modi govt allows 15-20% price hike in medicines that have ‘innovations’

Govt to allow pharma firms to increase price of drugs that are re-launched with “innovations” such as reduced side effects, or user-friendly administration techniques like skin patches.

On Camera

YourTurn

File photo of Assi Ghat, Varanasi | Representative Image | Neera Majumdar | ThePrint

Forget Gyanvapi for a moment, Varanasi needs justice for a recent carnage: 2006 IM bombings

The real victim of the Varanasi bombing investigation has been the idea of justice. It's more lethal than any bombs the Indian Mujahideen planted.
File image of Tata Group's headquarters in Mumbai | Photo: Dhiraj Singh | Bloomberg

Tata in acquisition talks with as many as 5 brands, to bolster position in consumer goods sector

The conglomerate will likely face stiff competition in the sector from existing global giants such as Unilever, as well as Indian tycoon Mukesh Ambani’s Reliance Industries.

Defence

Representational image of Pangong Tso | ThePrint

China building ‘bigger, broader’ 2nd bridge at Pangong Tso that can carry armoured columns

China's People's Liberation Army aims for multiple routes to counter any possible operations by the Indian forces on the southern banks of the Pangong Tso in the future.

How Congress is like the Ambassador & why Indian politics needs a brand new set of wheels

Like the car, nothing the party has done to reinvent itself has worked. Only way forward is to offer something looking towards the future, not in image of glorious past.
×